Literature DB >> 2070313

Hypercalcemia due to hyperparathyroidism treated with a somatostatin analogue.

D Miller1, M W Edmonds.   

Abstract

Entities:  

Mesh：

Substances：

Year:  1991        PMID： 2070313      PMCID： PMC1335728     

Source DB:  PubMed          Journal:  CMAJ        ISSN： 0820-3946            Impact factor:   8.262


× No keyword cloud information.
  4 in total

1.  Somatostatin analogue treatment for malignant hypercalcaemia.

Authors:  M Harrison; N James; K Broadley; S R Bloom; R Armour; S Wimalawansa; D Heath; J Waxman
Journal:  BMJ       Date:  1990-05-19

2.  Suppression of primary and secondary peptides with somatostatin analog in the therapy of functional endocrine tumors.

Authors:  E A Woltering; E J Mozell; T M O'Dorisio; W S Fletcher; B Howe
Journal:  Surg Gynecol Obstet       Date:  1988-12

Review 3.  Treatment of hypercalcemia.

Authors:  M F Attie
Journal:  Endocrinol Metab Clin North Am       Date:  1989-09       Impact factor: 4.741

4.  Parathyroid metabolism after operative treatment of hypercalcemic (primary) hyperparathyroidism.

Authors:  G L Irvin; D J Newell; S D Morgan
Journal:  Surgery       Date:  1987-12       Impact factor: 3.982
  4 in total
  1 in total

1.  Octreotide uptake in parathyroid adenoma.

Authors:  Seyhan Karaçavuş; Mustafa Kula; Züleyha Cihan Karaca; Kürşad Unlühızarcı; Ahmet Tutuş; Fahri Bayram; Ganime Coban
Journal:  Mol Imaging Radionucl Ther       Date:  2012-08-01
  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.